MinhTri Nguyen, MD (he/him)
@MinhTriMD
Followers
409
Following
1K
Media
33
Statuses
240
Medical Oncologist @StanfordHealth | H/Onc @ClevelandClinic | IM Chief @MHmedres CWRU | Physician leadership | Cert. Leadership Coach. My opinions are my own.
Joined June 2020
Physicians often promoted based on clinical acumen not leadership competency. Doing so, not only have you lost your best clinican, but now you' ve gained a lousy leader. EARLY & CONTINUOUS leadership training benefits docs, patients, orgs and healthcare. https://t.co/lbghhhJi3i
1
2
13
1/2📢Now out in @TheLancetOncol 📢 🔹Burnout now impacts 𝟱𝟵% of U.S. oncologists—up from 45% in 2013. This is no longer just a workforce issue—it’s a patient care crisis. 🔹Proud to join @ASCO, @COSAoncology & @EuropeanCancer in this global call to action for thriving,
Alongside @COSAoncology & @EuropeanCancer we have joined forces to issue a statement on healthy workplace cultures in the global oncology workforce. Read the full statement in @TheLancetOncol: https://t.co/G95CkH388x
2
10
28
Very big news out today-- adjuvant abemaciclib improves overall survival in high-risk ER+ breast cancer at ~7 yrs of f/u! Showing OS benefit in this setting is not easy & nice to see what an incredible impact adj cdk4/6i can have for our patients! https://t.co/pxI4RxPxXz
prnewswire.com
Treatment with Verzenio plus endocrine therapy demonstrated a statistically significant and clinically meaningful improvement in overall survival compared to...
13
65
201
A subset of patients with HER2+ metastatic breast cancer are cured by current therapies. Can we increase the rate of cured patients with patient selection & sequential use of the best anti-HER2 agents currently available? High hopes in the #SAPPHO phase 2 trial to bring answers.
The new #SAPPHO study, led by @DFCI_BreastOnc & @TheTBCRC, is evaluating a novel treatment approach for HER2+ #MetastaticBreastCancer. The study will help investigators understand if giving sequential treatments is safe and effective for patients with newly diagnosed HER2+ #MBC,
2
14
62
It was a privilege to work on this review with you @KimmieNgMD We highlight the rise in young-onset gastrointestinal cancers—current understanding, practical considerations, and future directions.
Honored to co-author this review article in @JAMA_current about the alarming rise in young-onset gastrointestinal cancers with @ThejusJay @DFarberYoungCRC @DanaFarberNews @DanaFarber
1
5
39
The journey from resident or fellow to a board-certified attending oncologist is a multifaceted and often daunting endeavor. @lungoncdoc @GIMedOnc @docbraunstein @nerealiamd @MinhTriMD
https://t.co/p24VlhEMF4
cancernetwork.com
Experts in the oncology field focused on ways to balance the transition from resident/fellow to attending.
1
3
8
Happening Now. @DFCI_BreastOnc and Dr. Waks debates standard of care in Stage II/III Her2+ Breast Cancer. Carboplatin addition to taxane HP does not improve pCR. EFS data still outstanding. Neuropathy worse with weekly abraxane, HP for 18 weeks than TCHP.
2
13
47
Evaluation and Treatment of Iron Deficiency for the Practicing Oncologist | JCO Oncology Practice https://t.co/n490rwztRu
@JCOOP_ASCO @ASCO @JCO_ASCO @OncoAlert
1
70
197
Stanford paid 35,000 people to quit social media. This was the largest study on emotional health in history. The results were so shocking, scientists called it "comparable to therapy." Here's what happens when you break free from the algorithm: đź§µ
543
6K
41K
Had a chance to speak with CancerNetwork alongside @lungoncdoc, @MinhTriMD, @nerealiamd and @docbraunstein about one of the most underdiscussed—and overwhelming—periods in our careers: preparing for the boards while transitioning from fellowship to faculty. The facts: 📚
cancernetwork.com
Read about various aspects of career trajectories in oncology from the perspective of established clinicians, new attendings, and those waiting to sit for their medical board exams.
3
10
32
What a thought provoking and stimulating ASCO for the breast cancer community! Still processing it all and looking forward hearing what others think of SERENA-6, DB-09, ASCENT-04 and beyond. #ASCO25 #CleClinicCancer
0
5
26
It's the last day of @ASCO #ASCO25 and the last day of #OntheClock ⏱️ with MedNews Week. In this clip, MinhTri Nguyen, MD, of @StanfordHealth, discusses the SERENA6 data with @YLeyfman Did he beat the clock? 👀
2
6
11
Camizestrant could reshape how we monitor and manage patients. “If a patient is found to have an #ESR1 mutation, the question [of SERENA-6] is whether we should switch aromatase inhibitors….We know that hormone-blocking therapies do not work well in this scenario. If we were to
1
1
0
Not everything fits cleanly in guidelines Real-world experience matters Experts respond quickly If you're in oncology, it's worth trying Primum for fast curbside consults:
0
0
2
Thank you @OncLive for the opportunity to share some insights on treatment landscape for #mTNBC and highlight some of the promising ongoing studies.
ADCs Are Poised to Transform the Metastatic TNBC Treatment Arsenal @OSUCCC_James @nerealiamd #BCSM #oncology
https://t.co/VGwA4IKL6d
2
4
17
What a weekend catching up with close friends, meeting with inspiring leaders, and chatting with fellows about how to navigate life as oncology attendings. Huge thanks to @Precisca for this distinctive annual tradition!
0
2
7
I make no generational judgement—disheartening to see burnout at all. Especially a field that clearly still holds joy for those that practice. The landscape is not what it used to be & we’ve trained to be nimble with medical decision—not staffing, prior auth, or EMR burden.
Trends in Well-Being and Burnout Among U.S. Oncologists: Challenges and Solutions @OncoAlert @JCOOP_ASCO @ASCO @EthicsdoctorP
https://t.co/cXx9TPHAkS
0
2
5
"Make a career of humanity. Commit yourself to the noble struggle for equal rights. You will make a better person of yourself, a greater nation of your country, and a finer world to live in." - MLK Jr I celebrate all of you living on his legacy by making a career of humanity.
0
0
2
My story. I review it from time to time to ask if I am the same author today. A time capsule of myself. From strawberries to stethoscopes: lessons in humanity from a future oncologist https://t.co/HJbUkEIKdx via @kevinmd
kevinmd.com
My personal journey from artichoke fields to oncology has taught me that true healing lies in compassion and humanity.
6
4
21
🔸Your most enduring professional legacy is not your CV — there will always be others with more papers, earnings, awards. Your most enduring professional legacy is... ...the people you've mentored. ▪️January is #NationalMentoringMonth.▪️Take time to celebrate your #oncology
1
28
78
I was born in the mountains of 🇻🇳. At 5 my parents sought the land of opportunity 🇺🇸. This Dec our family reunited in 🇻🇳. My country has changed and so have we. Change = opportunity. From my Fam: Happy new years! With the change, I hope you also find your opportunities to grow.
3
0
37